To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Podcast Cover

Hot Topics in Orthopaedics: Medicare Advantage Patient Characteristics and SSI Prevention Measures

Share
+ Favorites
Share
+ Favorites
February 22, 2023

Hot Topics in Orthopaedics: Medicare Advantage Patient Characteristics and SSI Prevention Measures

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE OrthoEvidence account

Already have an account? Click here
Loading...

The episode blends end-of-year reflection with two evidence-focused discussions. It opens with a light exchange about maintaining personal vision statements, emphasizing how clarifying one’s guiding words can streamline decisions and academic commitments. The conversation then turns to an important JBJS manuscript highlighting major demographic and clinical differences between patients in Medicare Advantage versus traditional Medicare—differences that challenge assumptions underlying U.S. administrative database research. Finally, the hosts examine the CHEETAH trial, a large, pragmatic study showing that a simple glove and instrument change before abdominal wound closure in low-resource settings reduced surgical site infections by 13%. The discussion underscores how low-cost perioperative steps may yield meaningful global benefits and how orthopaedics can draw from these lessons while pursuing future collaborative trials.

DISCLAIMER:

This podcast is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department.

The opinions, beliefs, and viewpoints expressed by the individuals on this podcast do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

Join the Conversation

Please Login or Join to leave comments.